Search Results for

Showing 41 - 50 of 76 results
  1. DCIM FAQs Portuguese

    DCIM FAQs Portuguese Perguntas Frequentes sobre o programa piloto deAdesão Institucional de Países em Desenvolvimento O que é o programa piloto de Adesão Institucional de Países em Desenvolvimento(DCIM)? O DCIM é o primeiro programa do género lançado pela ARVO. Nosso objetivo éajudar instituições de países em desenvolvimento a fortalecer seus atuaisprogramas de pesquisa sobre olho e visão, aliviando o fardo financeiro para queos pesquisadores participem da ARVO, dando-lhes acesso à comunidade

  2. Add a meeting

    Add a meeting Fill out the form below to add an event to the Vision Community Calendar. Fill out my online form. //

  3. CME

    Continuing Medical Education Program Educational objectives After completing this activity, the participant should be better able to:  Discuss the results of basic and clinical ophthalmology investigations and vision research underway, relevant to my area of interest or practice. Describe new models and methods being used by researchers and practitioners in eye and vision science.  Cite ways in which new research data and methods may influence my research and/or practice. Discuss prospec

  4. CME

    Continuing Medical Education Program Educational objectives After completing this activity, the participant should be better able to:  Discuss the results of basic and clinical ophthalmology investigations and vision research underway, relevant to my area of interest or practice. Describe new models and methods being used by researchers and practitioners in eye and vision science.  Cite ways in which new research data and methods may influence my research and/or practice. Discuss prospec

  5. Abstracts

    Abstracts Abstract submission is now closed. First authors were notified on April 20, 2018. For questions about abstracts, please send inquiries to: ooo@arvo.org or call 240.221.2900. Abstract reference tools Paper Presentation Guidelines Poster Presentation Guidelines Abstract Submission Policies and Procedures Abstract Submission FAQs Abstract Withdrawal and Substitute Presenter Policy Successful Abstract Submission Guidelines Commercial Relationship Disclosures Registering Clini

  6. Program

    Program Conference program The conference program includes podium sessions, with opening and closing keynote lectures, a tour of the Champalimaud Centre for the Unknown, poster sessions and multiple opportunities for attendees to network. Speakers are international experts in oncogenesis and oncology, from the Champalimaud Centre for the Unknown and other ophthalmic centers around the globe.  Program schedule overview Wednesday, July 18 – afternoon registration hours (Attendees may also che

  7. Election results

    Below are results of the voting that commenced at the ARVO 2018 Annual Meeting in Honolulu.  New AMPC members Anatomy and Pathology/Oncology (APO) Section – Anatomy sub-section Xiaoying Zhu, OD, PhD, MD, MS Anatomy and Pathology/Oncology (APO) Section – Pathology/Oncology sub-section Mohamed Abdel-Rahman, MD, PhD Biochemistry and Molecular Biology (BI) Section Elfride De Baere, MD, PhD Clinical/Epidemiologic Research (CL) Section Nicole Carnt, PhD, BOptom Cornea (CO) Section - Basic-scie

  8. Bylaws

    Bylaws ARTICLE 1.00 NAME AND PURPOSES OF THE ORGANIZATION ARTICLE 2.00 MEMBERSHIP ARTICLE 3.00 MEETINGS AND VOTE OF MEMBERS ARTICLE 4.00 BOARD OF TRUSTEES ARTICLE 5.00 PROCEEDINGS ARTICLE 6.00 COMMITTEES OF THE BOARD OF TRUSTEES ARTICLE 7.00 OFFICERS ARTICLE 8.00 MISCELLANEOUS    ARTICLE 9.00 AMENDMENTS     ARTICLE 1.00 NAME AND PURPOSES OF THE ORGANIZATION 1.01 This organization shall be known as the Association for Research in Vision and Ophthalmology, Inc., hereinafter referred to